| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $192.1M | — | +5.8% |
| Cost of Revenue | $59.2M | — | +4.0% |
| Gross Profit | $132.9M | — | +6.6% |
| R&D Expense | $17.9M | — | +2.7% |
| SG&A Expense | $36.4M | — | +17.3% |
| Operating Income | $24.6M | — | -5.4% |
| Pre-tax Income | $26.0M | — | -7.8% |
| Income Tax | $6.2M | — | +4.5% |
| Net Income | $19.7M | — | -11.1% |
| EPS (Basic) | $0.53 | — | -8.6% |
| EPS (Diluted) | $0.53 | — | -8.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $154.3M | +1.9% | +62.5% |
| Accounts Receivable | $65.1M | -4.5% | +2.7% |
| Current Assets | $328.7M | -2.0% | +30.5% |
| Total Assets | $1.16B | -0.7% | +4.7% |
| Current Liabilities | $154.9M | +0.4% | +1.0% |
| Total Liabilities | $199.0M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $55.6M | — | +39.1% |
| Capital Expenditures | $7.1M | — | +16.1% |
| Investing Cash Flow | -$7.1M | — | +95.2% |
| Financing Cash Flow | -$45.9M | — | -17.7% |
| Free Cash Flow | $48.5M | — | +43.3% |
| +5.8% |
| Stockholders' Equity | $962.2M | -1.2% | +4.5% |